Preclinical Evaluation of 131 I/ 18 F-Labeled Covalent Small-Molecule Inhibitors for STING Status Imaging
ACS Pharmacology & Translational Science · 14.06.2024 · 7 (6) · 1783-1794
DOI: 10.1021/acsptsci.3c00398 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Pharmacology & Translational Science, online erschienen am 09.05.2024. Verfasst von Jianyang Fang und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Vaccines for Infectious Diseases, Center for Molecular Imaging and Translational Medicine, Xiang An Biomedicine Laboratory, S…. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: China National Nuclear Corporation, China Postdoctoral Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
The stimulator of interferon genes (STING) is a vital protein to the immune surveillance of the tumor microenvironment. In this study, we develop novel inhibitor-based radioligands and evaluate their feasibility for noninvasive visualization of STING expression in tumor-bearing mice. Analogous compounds to STING inhibitors C170 and C176 were synthesized and labeled with 131I and 18F to attain [131I]I-NFIP and [18F]F-NFEP, respectively. The radiosynthesis was achieved with high radiochemical purity (>95%) and molar activity (28.56-48.89 GBq/μmol). The affinity and specificity of tracers were assessed through cell uptake and docking experiments, demonstrating that [131I]I-NFIP exhibited high specificity for STING, with a cell-based IC50 value of 7.56 nM. Small-animal PET/SPECT imaging and biodistribution studies in tumor-bearing mice models were performed to verify the tracers' pharmacokinetics and tumor-targeting capabilities (n = 3/group). SPECT imaging demonstrated that [131I]I-NFIP rapidly accumulated in the Panc02 tumor quickly at 30 min post-injection, with a tumor-to-muscle (T/M) ratio of 2.03 ± 0.30. This ratio significantly decreased in the blocking group (1.10 ± 0.14, **P < 0.01, n = 3). Furthermore, tumor uptake and the T/M ratio of [131I]I-NFIP were positively associated with STING expression. In summary, [131I]I-NFIP is the first STING-specific inhibitor-based radioligand offering the potential for visualizing STING status in tumors.
Autor:innen und Institutionen
- State Key Laboratory of Vaccines for Infectious Diseases, Center for Molecular Imaging and Translational Medicine, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, 4221-116 Xiang'An South Rd,…
- Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an 71003, China.
- Department of Nuclear Medicine and Minnan PET Center, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, Xiamen 361003, China.
- Theranostics and Translational Research Center, Institute of Clinical Medicine, Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College…
ORCID-Profile: Xiaobo Wang, Xianzhong Zhang, Zhide Guo
Förderung
- China National Nuclear Corporation
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
- National High-Level Hospital Clinical Research Funding
Zitieren
APA
Fang, J., Wang, X., Meng, L., Zhang, J., Zhuang, R., Li, Y., Zhang, X., & Guo, Z. (2024). Preclinical Evaluation of 131 I/ 18 F-Labeled Covalent Small-Molecule Inhibitors for STING Status Imaging. ACS Pharmacology & Translational Science, 7(6), 1783-1794. https://doi.org/10.1021/acsptsci.3c00398
Vancouver
Fang J, Wang X, Meng L, Zhang J, Zhuang R, Li Y, et al. Preclinical Evaluation of 131 I/ 18 F-Labeled Covalent Small-Molecule Inhibitors for STING Status Imaging. ACS Pharmacology & Translational Science. 2024;7(6):1783-1794. doi:10.1021/acsptsci.3c00398
BibTeX
@article{Fang2024,
author = {Fang, Jianyang and Wang, Xiaobo and Meng, Lingxin and Zhang, Jingru and Zhuang, Rongqiang and Li, Yesen and Zhang, Xianzhong and Guo, Zhide},
title = {Preclinical Evaluation of 131 I/ 18 F-Labeled Covalent Small-Molecule Inhibitors for STING Status Imaging},
journal = {ACS Pharmacology & Translational Science},
year = {2024},
volume = {7},
number = {6},
pages = {1783--1794},
doi = {10.1021/acsptsci.3c00398}
}
EUVIMED